• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性代谢缺陷的药物治疗导论

An Introduction to Pharmacotherapy for Inborn Errors of Metabolism.

作者信息

Harthan Aaron A

出版信息

J Pediatr Pharmacol Ther. 2018 Nov-Dec;23(6):432-446. doi: 10.5863/1551-6776-23.6.432.

DOI:10.5863/1551-6776-23.6.432
PMID:30697128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6336179/
Abstract

Inborn errors of metabolism comprise a wide array of diseases and complications in the pediatric patient. The rarity of these disorders limits the ability to conduct and review robust literature regarding the disease states, mechanisms of dysfunction, treatments, and outcomes. Often, treatment plans will be based on the pathophysiology associated with the disorder and theoretical agents that may be involved in the metabolic process. Medication therapies usually consist of natural or herbal products. Established efficacious pediatric doses for these products are difficult to find in tertiary resources, and adverse effects are routinely limited to single case reports. This review article attempts to summarize some of the more common inborn errors of metabolism in a manner that is applicable to pharmacists who will provide care for these patients.

摘要

先天性代谢缺陷在儿科患者中涵盖了各种各样的疾病和并发症。这些疾病的罕见性限制了开展和审查有关疾病状态、功能障碍机制、治疗方法及预后的丰富文献的能力。通常,治疗方案将基于与该疾病相关的病理生理学以及可能参与代谢过程的理论药物。药物治疗通常由天然或草药产品组成。在三级资源中很难找到这些产品已确定的有效儿科剂量,且不良反应通常仅限于单例报告。这篇综述文章试图以一种适用于将为这些患者提供护理的药剂师的方式,总结一些较为常见的先天性代谢缺陷。

相似文献

1
An Introduction to Pharmacotherapy for Inborn Errors of Metabolism.先天性代谢缺陷的药物治疗导论
J Pediatr Pharmacol Ther. 2018 Nov-Dec;23(6):432-446. doi: 10.5863/1551-6776-23.6.432.
2
Newborn screening for inborn errors of metabolism: a systematic review.新生儿代谢性遗传病筛查:一项系统综述
Health Technol Assess. 1997;1(11):i-iv, 1-95.
3
Inborn Errors of Metabolism in Pediatric Epilepsy.小儿癫痫中的先天性代谢缺陷
J Pediatr Pharmacol Ther. 2019 Sep-Oct;24(5):398-405. doi: 10.5863/1551-6776-24.5.398.
4
Isolated neonatal seizures: when to suspect inborn errors of metabolism.孤立性新生儿惊厥:何时怀疑先天性代谢缺陷。
Pediatr Neurol. 2011 Nov;45(5):283-91. doi: 10.1016/j.pediatrneurol.2011.07.006.
5
Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review.可治疗的导致智力障碍的先天性代谢缺陷:系统文献回顾。
Mol Genet Metab. 2012 Mar;105(3):368-81. doi: 10.1016/j.ymgme.2011.11.191. Epub 2011 Nov 30.
6
Movement Disorders in Treatable Inborn Errors of Metabolism.可治疗性先天性代谢缺陷相关的运动障碍。
Mov Disord. 2019 May;34(5):598-613. doi: 10.1002/mds.27568. Epub 2018 Dec 17.
7
Inborn errors of metabolism in infancy: a guide to diagnosis.婴儿期先天性代谢缺陷:诊断指南
Pediatrics. 1998 Dec;102(6):E69. doi: 10.1542/peds.102.6.e69.
8
Contemporary scope of inborn errors of metabolism involving epilepsy or seizures.当代涉及癫痫或发作的代谢性先天缺陷的范围。
Metab Brain Dis. 2018 Dec;33(6):1781-1786. doi: 10.1007/s11011-018-0288-1. Epub 2018 Jul 13.
9
Testing for Inborn Errors of Metabolism.先天性代谢缺陷检测
Continuum (Minneap Minn). 2018 Feb;24(1, Child Neurology):37-56. doi: 10.1212/CON.0000000000000563.
10
Carnitine supplementation for inborn errors of metabolism.补充肉碱治疗先天性代谢缺陷病。
Cochrane Database Syst Rev. 2009 Apr 15(2):CD006659. doi: 10.1002/14651858.CD006659.pub2.

引用本文的文献

1
Concordance Between Biochemical and Molecular Diagnosis Obtained by WES in Mexican Patients with Inborn Errors of Intermediary Metabolism: Utility for Therapeutic Management.基于 WES 的生化和分子诊断在墨西哥先天性代谢异常患者中的一致性:对治疗管理的实用性。
Int J Mol Sci. 2024 Oct 31;25(21):11722. doi: 10.3390/ijms252111722.
2
Parents' Perceptions Regarding Their Children's Medications and Expert-Assessed Drug-Related Problems in Pediatric Patients with Inborn Errors of Metabolism.先天性代谢缺陷儿科患者的父母对其子女用药的认知及专家评估的药物相关问题
Children (Basel). 2023 Nov 29;10(12):1873. doi: 10.3390/children10121873.
3
Biochemical phenotyping of paroxysmal nocturnal hemoglobinuria reveals solute carriers and β-oxidation deficiencies.阵发性睡眠性血红蛋白尿症的生化表型分析揭示溶质载体和β-氧化缺陷。
PLoS One. 2023 Aug 1;18(8):e0289285. doi: 10.1371/journal.pone.0289285. eCollection 2023.
4
Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds.碳-11 标记的内源性和天然外源性化合物的放射性合成、临床前和临床正电子发射断层扫描研究。
Chem Rev. 2023 Jan 11;123(1):105-229. doi: 10.1021/acs.chemrev.2c00398. Epub 2022 Nov 18.
5
Knowledge and perception of inborn errors of metabolism (IEMs) among healthcare students at a selected public university in Klang Valley, Malaysia.马来西亚巴生谷一所选定公立大学的医学生对先天性代谢缺陷(IEMs)的认知与了解。
Intractable Rare Dis Res. 2022 Aug;11(3):125-132. doi: 10.5582/irdr.2022.01062.
6
Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism.靶向代谢组学分析与传统代谢筛查在代谢缺陷疾病诊断中的比较
JAMA Netw Open. 2021 Jul 1;4(7):e2114155. doi: 10.1001/jamanetworkopen.2021.14155.
7
Animal Model Contributions to Congenital Metabolic Disease.动物模型对先天性代谢疾病的贡献。
Adv Exp Med Biol. 2020;1236:225-244. doi: 10.1007/978-981-15-2389-2_9.

本文引用的文献

1
Neonatal-onset carbamoyl phosphate synthetase I deficiency: A case report.新生儿期起病的氨甲酰磷酸合成酶I缺乏症:一例报告。
Medicine (Baltimore). 2017 Jun;96(26):e7365. doi: 10.1097/MD.0000000000007365.
2
Tyrosinemia type III in an asymptomatic girl.一名无症状女孩患III型酪氨酸血症。
Mol Genet Metab Rep. 2015 Oct 22;5:48-50. doi: 10.1016/j.ymgmr.2015.10.004. eCollection 2015 Dec.
3
Sapropterin treatment does not enhance the health-related quality of life of patients with phenylketonuria and their parents.四氢生物蝶呤治疗并不能提高苯丙酮尿症患者及其父母与健康相关的生活质量。
Acta Paediatr. 2017 Jun;106(6):953-959. doi: 10.1111/apa.13799. Epub 2017 Mar 19.
4
First Japanese Case of Carnitine Palmitoyltransferase II Deficiency with the Homozygous Point Mutation S113L.首例携带纯合子点突变S113L的日本肉碱棕榈酰转移酶II缺乏症病例。
Intern Med. 2016;55(18):2659-61. doi: 10.2169/internalmedicine.55.6288. Epub 2016 Sep 15.
5
Biotin Treatment Mimicking Graves' Disease.生物素治疗模拟格雷夫斯病。
N Engl J Med. 2016 Aug 18;375(7):704-6. doi: 10.1056/NEJMc1602096.
6
A caution regarding high-dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients.关于高剂量生物素疗法的一则警示:甲状腺功能正常患者的甲状腺功能亢进误诊。
Med J Aust. 2016 Aug 15;205(4):192. doi: 10.5694/mja16.00544.
7
Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis.晚期庞贝病患者接受阿糖苷酶 α 治疗后的生存和长期结局:系统评价和荟萃分析。
J Neurol. 2017 Apr;264(4):621-630. doi: 10.1007/s00415-016-8219-8. Epub 2016 Jul 2.
8
Riboflavin-Responsive and -Non-responsive Mutations in FAD Synthase Cause Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency.黄素腺嘌呤二核苷酸合成酶中对核黄素反应性和非反应性的突变导致多种酰基辅酶A脱氢酶缺乏症和联合呼吸链缺陷。
Am J Hum Genet. 2016 Jun 2;98(6):1130-1145. doi: 10.1016/j.ajhg.2016.04.006.
9
Homocystinuria: Therapeutic approach.高胱氨酸尿症:治疗方法。
Clin Chim Acta. 2016 Jul 1;458:55-62. doi: 10.1016/j.cca.2016.04.002. Epub 2016 Apr 6.
10
An unfortunate challenge: Ketogenic diet for the treatment of Lennox-Gastaut syndrome in tyrosinemia type 1.一个不幸的挑战:生酮饮食用于治疗1型酪氨酸血症中的伦诺克斯-加斯托综合征。
Eur J Paediatr Neurol. 2016 Jul;20(4):674-7. doi: 10.1016/j.ejpn.2016.02.015. Epub 2016 Mar 16.